Differentiating Diabetes mellitus type 1 from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 63: Line 63:
!✖
!✖
!Usually patients are young and lean
!Usually patients are young and lean
!
!
!'''↑'''
!'''↑'''
!'''↑'''
!'''↑'''
Line 93: Line 93:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|MODY
|MODY
Line 103: Line 103:
|✔
|✔
|✖
|✖
|
|
|
|
|'''↑'''
|'''↑'''
|'''↑'''
|'''↑'''
Line 112: Line 112:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|Psychogenic polydipsia
|Psychogenic polydipsia
Line 122: Line 122:
|✖
|✖
|✖
|✖
|
|
|
|
|N
|N
|N
|N
Line 131: Line 131:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|Diabetes insipidus
|Diabetes insipidus
Line 141: Line 141:
|✖
|✖
|✖
|✖
|
|
|
|
|N
|N
|N
|N
Line 150: Line 150:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|Transient hyperglycemia
|Transient hyperglycemia
Line 160: Line 160:
|✖
|✖
|✔
|✔
|
|
|
|
|'''↑'''
|'''↑'''
|'''↑'''
|'''↑'''
Line 169: Line 169:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|Steroid therapy
|Steroid therapy
Line 179: Line 179:
|✔
|✔
|✔
|✔
|
|
|Acanthosis nigricans
|Acanthosis nigricans
|'''↑'''
|'''↑'''
Line 188: Line 188:
|'''↑'''
|'''↑'''
|N
|N
|
|
|
|N
|-
|-
|RTA 1
|RTA 1
Line 198: Line 198:
|✖
|✖
|✖
|✖
|
|
|
|
|N
|N
|
|
|'''↓'''
|'''↓'''
|
|
Line 207: Line 207:
|N
|N
|N
|N
|
|
|
|N
|-
|-
|Glucagonoma
|Glucagonoma
Line 214: Line 214:
|✖
|✖
|✖
|✖
|
|
|✖
|✖
|
|
|
|
|―
|Necrolytic migratory erythema (NME) 
|'''↑'''
|'''↑'''
|
|
|
|
|
|
Line 226: Line 226:
|N
|N
|N
|N
|
|
|'''↑'''
|'''↑'''
|-
|-
|Cushing
|Cushing disease
|✖
|✖
|✖
|✖
Line 236: Line 236:
|✔
|✔
|✖
|✖
|Moon face,
|Patients can present with moon face,
Obese and buffalo hump
obesity and buffalo hump
|Acanthosis nigricans
|Acanthosis nigricans
|'''↑'''
|'''↑'''
|
|
|
|
|'''N'''
|'''N'''
Line 246: Line 246:
|'''↑'''
|'''↑'''
|N
|N
|
|
|
|N
|-
|-
|Hypothyroidism
|Hypothyroidism
Line 256: Line 256:
|✔
|✔
|✖
|✖
|
|Patients may present with weight gain and swelling of face
|
|
|N
|N
|
|
|
|
|'''N'''
|'''N'''
Line 265: Line 265:
|N
|N
|N
|N
|
|Antibodies assocaited with hypothyroidism are:
|
* Thyroid Peroxidase Antibody
|-
* Thyroglobulin Antibody
|
* Thyroid Stimulating Hormone Receptor Antibody
|
|N
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|}
|}
</SMALL></SMALL>


==References==
==References==

Revision as of 16:05, 28 December 2016

Diabetes mellitus main page

Diabetes mellitus type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Diabetes mellitus type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Dietary Management

Medical Therapy

Surgery

Strategies for Improving Care

Foundations of Care and Comprehensive Medical Evaluation

Diabetes Self-Management, Education, and Support
Nutritional Therapy

Glycemic Targets

Approaches to Glycemic Treatment

Cardiovascular Disease and Risk Management

Hypertension and Blood Pressure Control
Lipid Management
Antiplatelet Agents
Coronary Heart Disease

Microvascular Complications and Foot Care

Diabetic Kidney Disease
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Footcare

Older Adults with Diabetes

Children and Adolescents with Diabetes

Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes
Microvascular Complications in Children and Adolescents with Diabetes

Management of Diabetes in Pregnancy

Diabetes Care in the Hospital Setting

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Diabetes mellitus Main page

Patient Information

Type 1
Type 2

Overview

Classification

Diabetes mellitus type 1
Diabetes mellitus type 2
Gestational diabetes

Differential Diagnosis

Complications

Screening

Diagnosis

Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Type 1 DM must be differentiated from type 2 DM, MODY-DM, psychogenic polydipsia, diabetes insipidus, transient hyperglycemia, steroid therapy, renal tubular acidosis type-1, glucagonoma, cushing's syndrome, and hypothyroidism.

Differentiating Diabetes mellitus type 1 from other Diseases

Differential diagnosis of type 1 DM, include: [1][2]

History and symptoms Physical examination Investigations
Polyuria Polydipsia Polyphagia Weight loss Weight gain Positive medical history General appearance Skin manifestations Serum glucose Urinary Glucose Urine Ph Serum Sodium Urinary Glucose 24 hrs cortisol level C-peptide level Auto antibodies Serum glucagon
Type 1 Diabetes mellitus Usually patients are young and lean N N N
  • Measurements of IA2 autoantibodies within 6 months of diagnosis can help differentiate between type 1 and type 2 DM
  • Anti-GAD65 usually present
  • Anti-insulin autoantibodies usually present
Type 2 Diabetes mellitus Usually patients are middle age or elderly and obese Acanthosis nigricans N N N N N
MODY N N N N N
Psychogenic polydipsia N N N N N N N
Diabetes insipidus N N N N N N
Transient hyperglycemia N N N N N
Steroid therapy Acanthosis nigricans N N
RTA 1 N N N N
Glucagonoma Necrolytic migratory erythema (NME)  N N
Cushing disease Patients can present with moon face,

obesity and buffalo hump

Acanthosis nigricans N N/ N N
Hypothyroidism Patients may present with weight gain and swelling of face N N N N N Antibodies assocaited with hypothyroidism are:
  • Thyroid Peroxidase Antibody
  • Thyroglobulin Antibody
  • Thyroid Stimulating Hormone Receptor Antibody
N

References

  1. Barrett TG (2007). "Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered?". Pediatr Diabetes. 8 Suppl 6: 15–23. doi:10.1111/j.1399-5448.2007.00278.x. PMID 17727381.
  2. Type 1 Diabetes mellitus "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 27th,2016

Template:WH Template:WS